POSA25 An Incremental Effectiveness Analysis of Avelumab in Combination With Axitinib for the Treatment of First-Line Advanced Renal Cell Carcinoma in Portugal
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.098
https://www.valueinhealthjournal.com/article/S1098-3015(21)01893-3/fulltext
Section Title :
Section Order :
10610
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01893-3&doi=10.1016/j.jval.2021.11.098